Pilot trial of 1% pimecrolimus cream in the treatment of seborrheic dermatitis in African American adults with associated hypopigmentation
- 30 June 2006
- journal article
- research article
- Published by Elsevier BV in Journal of the American Academy of Dermatology
- Vol. 54 (6), 1083-1088
- https://doi.org/10.1016/j.jaad.2006.01.011
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- Skin function and skin disorders in Parkinson’s diseaseJournal of Neural Transmission, 2001
- The Effects of Malassezia Yeasts on Cytokine Production by Human KeratinocytesJournal of Investigative Dermatology, 2001
- Quantitative culture ofMalasseziaspecies from different body sites of individuals with or without dermatosesMedical Mycology, 2001
- Identification ofMalasseziaspecies isolated from patients with seborrhoeic dermatitis, atopic dermatitis, pityriasis versicolor and normal subjectsMedical Mycology, 2000
- Malassezia spp Carriage in Patients with Seborrheic DermatitisThe Journal of Dermatology, 1999
- Seborrhoeic dermatitis is not caused by an altered immune response toMalasseziayeastBritish Journal of Dermatology, 1998
- A double-blind trial of treatment of seborrhoeic dermatitis with 2% ketoconazole cream compared with 1% hydrocortisone creamBritish Journal of Dermatology, 1989
- Ketoconazole 2% cream versus hydrocortisone 1% cream in the treatment of seborrheic dermatitis: A double-blind comparative studyJournal of the American Academy of Dermatology, 1988
- Seborrheic dermatitis in patients with acquired immunodeficiency syndromeJournal of the American Academy of Dermatology, 1985
- Double-blind treatment of seborrheic dermatitis with 2% ketoconazole creamJournal of the American Academy of Dermatology, 1985